ACE2 and COVID-19: As already discussed, the COVID-19 entry process is mediated by binding SARS-CoV-2 spike receptor-binding domain (RBD) domain to ACE2 [7] However, some studies have reported susceptibility to the virus in intra- and extra-pulmonary immune and non-immune cells lacking ACE2 [8].